BioLexa

N/A

Report date: 2024/04/29 14:58:54
NME

Base Information

Drug NameBioLexa
Drug Alias NameGentamicin/Diethylenetriaminepentaacetic acidBioLexa™
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of Action30S ribosomal subunit inhibitorsChelating agents
Targets30S ribosomal subunit
Therapy Area/IndicationsEczemaDermatitis, Atopic
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryAustralia
CombinationsYes
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesUniversity Of Cincinnati
China Registration ClassN/A

Develop Information

Active CompaniesHoth Therapeutics Inc
Inactive CompaniesN/A
Active IndicationsDermatitis, Atopic
Inactive IndicationsEczema

Other Information

ATC CodeN/A
Related LinksN/A